Published in Gastroenterology on April 01, 1996
Global prevalence of putative haemochromatosis mutations. J Med Genet (1997) 4.03
A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium. Gut (1997) 3.49
Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload. Hepatology (2015) 3.40
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut (2003) 2.96
Controversy in primary care: Should asymptomatic haemochromatosis be treated? BMJ (2000) 2.36
Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (2011) 2.28
Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology (2012) 1.91
Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut (2001) 1.88
Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase. Gut (2000) 1.74
Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol (2009) 1.68
The case for strengthening education and training for general practice. Br J Gen Pract (2001) 1.61
HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut (2000) 1.47
Total mortality by elevated transferrin saturation in patients with diabetes. Diabetes Care (2013) 1.43
Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled. BMJ (1999) 1.28
The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut (1998) 1.25
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets (2012) 1.23
Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut (2007) 1.21
CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies. Genet Med (2010) 1.21
Liver iron content determination by magnetic resonance imaging. World J Gastroenterol (2010) 1.21
Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can J Gastroenterol (2008) 1.19
The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet (2004) 1.09
Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases? J Med Genet (2005) 1.08
Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet (1999) 1.06
Iron storage disease: facts, fiction and progress. Blood Cells Mol Dis (2007) 1.05
Comparison of whole liver and small region-of-interest measurements of MRI liver R2* in children with iron overload. Pediatr Radiol (2010) 1.05
Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse. BMC Genomics (2007) 1.00
Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev (2006) 0.99
Hemochromatosis: the impact of early diagnosis and therapy. Gastroenterology (1996) 0.99
Molecular and clinical aspects of iron homeostasis: From anemia to hemochromatosis. Wien Klin Wochenschr (2006) 0.97
Haemochromatosis and exercise related joint pains. BMJ (1999) 0.97
Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol (2007) 0.96
Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients. Gut (2005) 0.96
Incidence of liver disease in people with HFE mutations. Gut (2000) 0.96
Bone status in a mouse model of genetic hemochromatosis. Osteoporos Int (2010) 0.95
Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases. Front Aging Neurosci (2013) 0.95
Non-HFE hemochromatosis. Rev Bras Hematol Hemoter (2012) 0.95
The mortality risk of elevated serum transferrin saturation and consumption of dietary iron. Ann Fam Med (2004) 0.93
Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol (2010) 0.90
Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis. J Exp Clin Cancer Res (2010) 0.90
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology (2010) 0.88
Insulin resistance and chronic liver disease. World J Hepatol (2011) 0.88
Individuals homozygous for the H63D mutation have significantly elevated iron indexes. Dig Dis Sci (2006) 0.87
Hereditary haemochromatosis: never seen a case? Br J Gen Pract (2001) 0.87
The global burden of iron overload. Hepatol Int (2009) 0.87
Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan. World J Gastroenterol (2005) 0.86
Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells. Osteoporos Int (2012) 0.86
Physiology and pathophysiology of iron in hemoglobin-associated diseases. Free Radic Biol Med (2014) 0.85
Development of a multiplex ARMS test for mutations in the HFE gene associated with hereditary haemochromatosis. J Clin Pathol (1998) 0.85
Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma. Biomark Cancer (2016) 0.85
Pathogenic Mechanisms Underlying Iron Deficiency and Iron Overload: New Insights for Clinical Application. EJIFCC (2009) 0.84
Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network. Am J Hum Genet (2015) 0.84
Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study. BMC Gastroenterol (2005) 0.84
Iron homeostasis in the liver. Compr Physiol (2013) 0.84
Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy. Dig Dis Sci (2016) 0.83
Predictive value of family history in diagnosis of hereditary hemochromatosis. Dig Dis Sci (1997) 0.83
The diagnosis and management of hereditary haemochromatosis. Clin Biochem Rev (2010) 0.82
Targeted screening for genetic haemochromatosis: a combined phenotype/genotype approach. J Clin Pathol (2006) 0.82
Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care (2008) 0.81
Heart failure and malignant ventricular tachyarrhythmias due to hereditary hemochromatosis with iron overload cardiomyopathy. Clin Res Cardiol (2007) 0.81
Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis. Gut (2000) 0.81
EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH). Eur J Hum Genet (2015) 0.81
Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data. BMC Med Genet (2005) 0.80
Evidence for altered hepatic matrix degradation in genetic haemochromatosis. Gut (1998) 0.80
Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy. Ann Hematol (2012) 0.79
Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Hematology Am Soc Hematol Educ Program (2009) 0.78
The H63D variant in the HFE gene predisposes to arthralgia, chondrocalcinosis and osteoarthritis. Ann Rheum Dis (2007) 0.78
Non-viral causes of hepatocellular carcinoma. J Gastrointest Cancer (2011) 0.78
Hemochromatosis. More common than you think. Can Fam Physician (2003) 0.77
Liver transplantation(). J Ultrasound (2007) 0.77
A patient with a rare cause of elevated troponin I. Clin Res Cardiol (2015) 0.77
Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload. Eur J Haematol (2010) 0.76
The Regulation of Iron Absorption and Homeostasis. Clin Biochem Rev (2016) 0.76
Diagnosis of hereditary hemochromatosis in the era of genetic testing. Dig Dis Sci (2012) 0.76
Screening in liver disease. World J Gastroenterol (2006) 0.76
Sudden cardiac death in hereditary hemochromatosis: an underestimated cause of death? Int J Legal Med (2004) 0.76
Prevention of hepatocellular carcinoma. HPB (Oxford) (2005) 0.76
Nutrition and Hepatocellular Cancer. Gastrointest Tumors (2015) 0.75
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 159: 52-year-old patient with psoriasis and arthralgia of the finger joints. Wien Klin Wochenschr (2016) 0.75
Management of human factors engineering-associated hemochromatosis: A 2015 update. World J Hepatol (2016) 0.75
Hemochromatosis. Common genes, uncommon illness? Can Fam Physician (2002) 0.75
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron). BMJ Open (2015) 0.75
Haemochromatosis: a gene at last? J Med Genet (1997) 0.75
Heteroduplex analysis for the three common HFE variants: methodology, reliability and analysis of over 5000 requests for testing. J Clin Pathol (2006) 0.75
Key-interventions derived from three evidence based guidelines for management and follow-up of patients with HFE haemochromatosis. BMC Health Serv Res (2016) 0.75
Clinical utility gene card for: Haemochromatosis [HFE]. Eur J Hum Genet (2010) 0.75
Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report. Neth Heart J (2009) 0.75
Hepatobiliary quiz-3 (2012). J Clin Exp Hepatol (2012) 0.75
Ironing out the rough spots--cognitive impairment in haemochromatosis. BMJ Case Rep (2012) 0.75
Diabetes and HFE mutations: cause or coincidence? West J Med (2002) 0.75
A diagnostic approach to hemochromatosis. Can J Gastroenterol (2006) 0.75
Diabetes in HFE Hemochromatosis. J Diabetes Res (2017) 0.75
Inherited disorders of transition metal metabolism: an update. J Inherit Metab Dis (2017) 0.75
[Hereditary hemochromatosis, alpha-1-antitrypsin deficiency and Wilson's disease. Pathogenesis, clinical findings and pathways to diagnosis]. Pathologe (2008) 0.75
Uncoupled iron homeostasis in type 2 diabetes mellitus. J Mol Med (Berl) (2017) 0.75
Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell (1991) 5.65
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09
Functional significance of cell volume regulatory mechanisms. Physiol Rev (1998) 4.59
Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature (1997) 4.03
Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med (1991) 3.73
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med (1985) 3.73
National character does not reflect mean personality trait levels in 49 cultures. Science (2005) 3.56
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med (1996) 3.41
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med (1995) 3.20
Surgical management of complicated colonic diverticulitis. Br J Surg (1997) 3.17
A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol Cell Biol (1991) 3.13
Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology (1998) 3.00
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology (1990) 2.99
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med (1998) 2.91
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut (2006) 2.53
Macrolide-induced Churg-Strauss syndrome in a patient with atopy. Lancet (1997) 2.42
Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A (1994) 2.41
Structure and dynamics of human interphase chromosome territories in vivo. Hum Genet (1998) 2.39
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest (1997) 2.32
A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol Cell Biol (1991) 2.27
Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol (1998) 2.26
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ (2005) 2.25
Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy (2006) 2.24
Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis. Aliment Pharmacol Ther (2014) 2.15
Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty. Circulation (1999) 2.13
Risk of infection with Helicobacter pylori and hepatitis A virus in different groups of hospital workers. Am J Gastroenterol (1997) 2.09
Intratesticular leiomyosarcoma in a young man after high dose doping with Oral-Turinabol: a case report. Cancer (1999) 2.03
[Demonstration of HFE polymorphism in German patients with hereditary hemochromatosis]. Dtsch Med Wochenschr (1999) 2.03
Tomato Ve disease resistance genes encode cell surface-like receptors. Proc Natl Acad Sci U S A (2001) 2.03
Pancreatic exocrine secretion in acute experimental pancreatitis. Gastroenterology (1990) 2.02
Lead overload in patients with renal insufficiency. Nephron (1990) 2.02
High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine (2000) 1.92
Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology (1999) 1.87
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest (1998) 1.86
Climate change and the integrity of science. Science (2010) 1.80
Predictors of duodenal ulcer healing and relapse. Gastroenterology (1981) 1.78
Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy (2008) 1.76
Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res (1992) 1.75
Complete primary structure of a human plasma membrane Ca2+ pump. J Biol Chem (1988) 1.75
Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology (1997) 1.70
Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.68
Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells. Gastroenterology (2001) 1.66
Motor analysis predicts progression in HIV-associated brain disease. J Neurol Sci (1994) 1.64
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ (2004) 1.62
Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood (1993) 1.62
Hepatorenal reflex regulating kidney function. Hepatology (1991) 1.61
Prospective study on the detection of insulinomas by endoscopic ultrasonography. Endoscopy (1996) 1.61
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology (1988) 1.56
Isolation and partial characterization of a fatty acid binding protein in rat liver plasma membranes. Proc Natl Acad Sci U S A (1985) 1.55
Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: a randomized trial. Hepatology (1996) 1.53
A light- and temperature-entrained circadian clock controls expression of transcripts encoding nuclear proteins with homology to RNA-binding proteins in meristematic tissue. Plant J (1994) 1.53
Late diagnosis of Wilson's disease in a case without onset of symptoms. Acta Neurol Scand (1995) 1.52
Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol (1994) 1.52
Plasmodium knowlesi infection imported to Germany, January 2013. Euro Surveill (2013) 1.50
Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc Natl Acad Sci U S A (1986) 1.50
Cortical origin of mini-asterixis in hepatic encephalopathy. Neurology (2002) 1.50
Identification and primary structure of a calmodulin binding domain of the Ca2+ pump of human erythrocytes. J Biol Chem (1988) 1.50
Nuclear traffic in fungal hyphae: in vivo study of nuclear migration and positioning in Aspergillus nidulans. Mol Microbiol (1997) 1.50
Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology (1993) 1.49
Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol (2001) 1.48
Increased risk of bacterial endocarditis in inflammatory bowel disease. Am J Med (1992) 1.47
Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. Am J Surg (1978) 1.47
Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. J Clin Pathol (1994) 1.47
LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett (1999) 1.46
Anal endosonography and manometry: comparison in patients with defecation problems. Dis Colon Rectum (1997) 1.46
Hepatocyte heterogeneity in glutamine and ammonia metabolism and the role of an intercellular glutamine cycle during ureogenesis in perfused rat liver. Eur J Biochem (1983) 1.43
Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med (1998) 1.42
Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol (2000) 1.42
Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs (1999) 1.42
Actions of extracellular UTP and ATP in perfused rat liver. A comparative study. Eur J Biochem (1987) 1.40
[Recommendation for primary resection with primary anastomosis in complicated sigmoid diverticulitis. Report of experiences of the Herford Surgical Clinic 1973 to 1986]. Langenbecks Arch Chir (1989) 1.40
Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect Immun (2001) 1.40
[Increased gamma-GT (gamma-glutamyltransferase): causes and interpretations]. Dtsch Med Wochenschr (1994) 1.38
Ultrastructure of megakaryocytes in the human bone marrow of patients with primary (essential) thrombocythemia. J Submicrosc Cytol Pathol (1988) 1.38
DNA sequence of regulatory region for integration gene of bacteriophage lambda. Proc Natl Acad Sci U S A (1980) 1.36
The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat. Nat Med (1999) 1.35
Establishment of persistent hepatitis C virus infection and replication in vitro. J Gen Virol (1997) 1.35
The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol (2005) 1.34
Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology (1994) 1.34
Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers. Immunotechnology (1996) 1.34
Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma. Dig Dis Sci (1997) 1.34
Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab (1997) 1.32
Water, K+, H+, lactate and glucose fluxes during cell volume regulation in perfused rat liver. Pflugers Arch (1989) 1.31
Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry. Scand J Gastroenterol (2004) 1.29
Characterization and natural course of cardiac autonomic nervous dysfunction in HIV-infected patients. AIDS (1997) 1.29
Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut (2005) 1.28
Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection. Clin Exp Immunol (1998) 1.27
Peptide sequence analysis and molecular cloning reveal two calcium pump isoforms in the human erythrocyte membrane. J Biol Chem (1990) 1.26
Hepatocellular influx of [14C]oleate reflects membrane transport rather than intracellular metabolism or binding. Proc Natl Acad Sci U S A (1986) 1.26
The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro (2004) 1.25
Molecular characterization of HymA, an evolutionarily highly conserved and highly expressed protein of Aspergillus nidulans. Mol Gen Genet (1999) 1.25
Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J Gen Virol (2007) 1.25